A. Lavolé

3.4k total citations
105 papers, 1.7k citations indexed

About

A. Lavolé is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, A. Lavolé has authored 105 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pulmonary and Respiratory Medicine, 65 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in A. Lavolé's work include Lung Cancer Treatments and Mutations (49 papers), Lung Cancer Diagnosis and Treatment (35 papers) and Viral-associated cancers and disorders (25 papers). A. Lavolé is often cited by papers focused on Lung Cancer Treatments and Mutations (49 papers), Lung Cancer Diagnosis and Treatment (35 papers) and Viral-associated cancers and disorders (25 papers). A. Lavolé collaborates with scholars based in France, United States and United Kingdom. A. Lavolé's co-authors include Marie Wislez, Jacques Cadranel, B. Milleron, V. Gounant, Anne-Marie Ruppert, Martine Antoine, Antoine Parrot, Nathalie Rabbe, Vincent Cottin and Thierry Chinet and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Clinical Cancer Research.

In The Last Decade

A. Lavolé

99 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Lavolé France 24 916 897 254 187 164 105 1.7k
Renata Langfort Poland 19 594 0.6× 904 1.0× 162 0.6× 168 0.9× 40 0.2× 145 1.6k
Silvia Park South Korea 21 581 0.6× 206 0.2× 178 0.7× 260 1.4× 203 1.2× 163 1.5k
H. Bodenstein Germany 17 699 0.8× 667 0.7× 128 0.5× 98 0.5× 219 1.3× 39 1.8k
Shogo Banno Japan 19 275 0.3× 270 0.3× 148 0.6× 319 1.7× 192 1.2× 91 1.1k
Almalina Bacigalupo Italy 21 716 0.8× 603 0.7× 79 0.3× 182 1.0× 149 0.9× 81 1.8k
Bernard R. Greenberg United States 19 554 0.6× 238 0.3× 182 0.7× 249 1.3× 303 1.8× 64 1.5k
Giovanni Franchin Italy 25 646 0.7× 852 0.9× 116 0.5× 152 0.8× 133 0.8× 109 2.0k
Azael Freites‐Martínez Spain 14 566 0.6× 259 0.3× 212 0.8× 110 0.6× 79 0.5× 47 1.2k
Chrystia M. Slywotzky United States 13 321 0.4× 282 0.3× 98 0.4× 243 1.3× 79 0.5× 17 998
Larisa V. Debelenko United States 22 787 0.9× 453 0.5× 690 2.7× 187 1.0× 43 0.3× 45 1.8k

Countries citing papers authored by A. Lavolé

Since Specialization
Citations

This map shows the geographic impact of A. Lavolé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lavolé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lavolé more than expected).

Fields of papers citing papers by A. Lavolé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lavolé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lavolé. The network helps show where A. Lavolé may publish in the future.

Co-authorship network of co-authors of A. Lavolé

This figure shows the co-authorship network connecting the top 25 collaborators of A. Lavolé. A scholar is included among the top collaborators of A. Lavolé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lavolé. A. Lavolé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wislez, Marie, Charlotte Domblides, Laurent Greillier, et al.. (2021). Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA). Lung Cancer. 157. 124–130. 5 indexed citations
2.
Wislez, Marie, Vincent Fallet, Jalal Assouad, et al.. (2021). Parcours de diagnostic rapide du cancer du poumon : évaluation à un an. Revue des Maladies Respiratoires. 38(9). 904–913. 3 indexed citations
3.
Lavolé, A., Laurent Greillier, Julien Mazières, et al.. (2020). First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trial. European Respiratory Journal. 56(2). 1902066–1902066. 7 indexed citations
4.
Coffy, Amandine, Alexandra Langlais, Jean‐Pierre Daurès, et al.. (2020). Development and Validation of a Simplified Prognostic Score in SCLC. JTO Clinical and Research Reports. 1(1). 100016–100016. 1 indexed citations
5.
Lavolé, A., Julien Mazières, S. Schneider, et al.. (2020). 1389P IFCT-1602 CHIVA2 phase II trial: Nivolumab in previously treated HIV-patients with advanced non-small cell lung cancer (NSCLC). Annals of Oncology. 31. S882–S883. 4 indexed citations
6.
Wislez, Marie, Julien Mazières, A. Lavolé, et al.. (2020). 1214O Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO). Annals of Oncology. 31. S794–S794. 40 indexed citations
7.
Cadranel, J., Anthony Canellas, Antoine Parrot, et al.. (2019). Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer. European Respiratory Review. 28(153). 190058–190058. 69 indexed citations
8.
Ruppert, Anne-Marie, A. Lavolé, Jalal Assouad, Jacques Cadranel, & Marie Wislez. (2016). Place des traitements complémentaires pour les cancers bronchiques non à petites cellules opérables non N2. Bulletin du Cancer. 104(1). 79–85. 1 indexed citations
9.
Makinson, Alain, Vincent Le Moing, Jacques Reynes, et al.. (2016). Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working Group. Journal of Thoracic Oncology. 11(10). 1644–1652. 7 indexed citations
10.
Bruyand, Mathias, A. Lavolé, Karen Leffondré, et al.. (2015). Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients. AIDS. 29(9). 1105–1109. 7 indexed citations
11.
Moro‐Sibilot, Denis, Clarisse Audigier-Valette, P. Merle, et al.. (2015). Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study). Lung Cancer. 89(2). 139–145. 8 indexed citations
12.
Vieira, Thibault, Martine Antoine, Anne-Marie Ruppert, et al.. (2014). Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung. Lung Cancer. 85(2). 276–281. 63 indexed citations
13.
Duruisseaux, M., Martine Antoine, Nathalie Rabbe, et al.. (2014). The impact of intracytoplasmic mucin in lung adenocarcinoma with pneumonic radiological presentation. Lung Cancer. 83(3). 334–340. 20 indexed citations
14.
Fallet, Vincent, Anne-Marie Ruppert, Virginie Poulot, et al.. (2012). Secondary Resistance to Erlotinib: Acquired T790M Mutation and Small-Cell Lung Cancer Transformation in the Same Patient. Journal of Thoracic Oncology. 7(6). 1061–1063. 16 indexed citations
15.
Ruppert, Anne-Marie, Julie Fillon, A. Lavolé, et al.. (2011). Skin Toxicities Compromise Prolonged Pemetrexed Treatment. Journal of Thoracic Oncology. 6(12). 2083–2089. 28 indexed citations
16.
Giroux‐Leprieur, Etienne, A. Lavolé, Anne-Marie Ruppert, et al.. (2011). Factors associated with long‐term survival of patients with advanced non‐small cell lung cancer. Respirology. 17(1). 134–142. 42 indexed citations
17.
Gounant, V., B. Milleron, Jalal Assouad, et al.. (2009). Bevacizumab et actes invasifs : recommandations pratiques. Revue des Maladies Respiratoires. 26(2). 221–226. 5 indexed citations
18.
Cadranel, Jacques, Marie Wislez, V. Gounant, et al.. (2007). Prise en charge thérapeutique des adénocarcinomes de type bronchiolo-alvéolaires étendus : chimiothérapie ou inhibiteurs de la tyrosine kinase du récepteur de l’epidermal growth factor ?. Revue de Pneumologie Clinique. 63(3). 147–154. 1 indexed citations
19.
Cottin, Vincent, Thierry Chinet, A. Lavolé, et al.. (2007). Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia. Medicine. 86(1). 1–17. 135 indexed citations
20.
Lavolé, A., Marie Wislez, Martine Antoine, et al.. (2005). Lung cancer, a new challenge in the HIV-infected population. Lung Cancer. 51(1). 1–11. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renata Langfort Breakdown of academic impact, for papers by Silvia Park Breakdown of academic impact, for papers by H. Bodenstein Breakdown of academic impact, for papers by Shogo Banno Breakdown of academic impact, for papers by Almalina Bacigalupo Breakdown of academic impact, for papers by Bernard R. Greenberg Breakdown of academic impact, for papers by Giovanni Franchin Breakdown of academic impact, for papers by Azael Freites‐Martínez Breakdown of academic impact, for papers by Chrystia M. Slywotzky Breakdown of academic impact, for papers by Larisa V. Debelenko
Rankless by CCL
2026